Photo of Brian Kopell

Brian Kopell

Print ProfilePrint Profile


  • Neurological Surgery

Clinical Focus


  • MD, New York University School of Medicine

  • Internship, Surgery
    NYU Medical Center

  • Residency, Neurosurgery
    NYU Medical Center

  • Fellowship, Neurosurgery
    Cleveland Clinic Foundation


    A graduate of the NYU School of Medicine, Dr. Kopell completed his residency at NYU Medical Center. Dr. Kopell has undergone fellowship training in Functional and Restorative Neurosurgery at the Cleveland Clinic Foundation and the University of Zurich. He founded and has led the Restorative Neuroscience Program at the Medical College of Wisconsin (Milwaukee, WI) where his team performed over 400 Deep Brain Stimulation cases for movement disorders. Furthermore, Dr. Kopell has participated and has been principal investigator in several clinical trials of emerging Neuromodulation technologies targeting such disorders as Parkinson's Disease, tremor, tinnitus, Tourette's Syndrome and Major Depression. Now the Director of the Center for Neuromodulation, Dr. Kopell has pioneered the use of intraoperative imaging during Deep Brain Stimulation (DBS) cases to supplement the microelectrode recording typically done to make a procedure that is safer and quicker for patients.

    Deep Brain Stimulation (DBS) is widely recognized as the gold-standard treatment for patients with disabling motor symptoms from idiopathic Parkinson's Disease, Essential Tremor, and Dystonia that have become refractory to medical therapy. This neurosurgical procedure is available within a fully integrated multidisciplinary program through the Mount Sinai Medical Center.

    In the News: Dr. Brian Kopell discusses the results of neuromodulation in The New York Daily News feature,The Daily Check Up.



Intraoperative Image-Guidance for Deep Brain StimulationCortical Stimulation for TinnitusCortical and Deep Brain Stimulation for Depression and Obsessive Compulsive Disorder

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Kopell during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • MRI Interventions, Inc.; Medtronic, Inc.; St. Jude Medical, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.

Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.

Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


Annenberg Building Floor 8 Room 40
1468 Madison Avenue
New York, NY 10029

Tel: 212-241-0050
Mount Sinai Doctors Faculty Practice

5 East 98th Street
7th Floor
New York, NY 10029

Tel: 212-241-0050
Fax: 212-410-0603
Get Directions

Office Hours:
  • Thursday 9:00am - 5:00pm
Insurance Plans
  • Call Office to Inquire